Atlas Trials

Acute Anxiolytic Effects of Riluzole on Subjects With Social Anxiety Disorder

Clinical trial NCT03017508 · COMPLETED

Trial details

NCT number
NCT03017508
Sponsor
Yale University
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Social Anxiety DisorderPerformance Anxiety
Start date
2017-01-01
Primary completion
2019-12-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.